BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22791882)

  • 21. The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9.
    Georgakis GV; Li Y; Younes A
    Br J Haematol; 2006 Oct; 135(1):68-71. PubMed ID: 16925576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1.
    Lo RK; Kwong YL
    Ann Hematol; 2014 Feb; 93(2):255-65. PubMed ID: 23949314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
    Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
    Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
    Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
    Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
    Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
    Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma.
    Jin L; Tabe Y; Kimura S; Zhou Y; Kuroda J; Asou H; Inaba T; Konopleva M; Andreeff M; Miida T
    Br J Cancer; 2011 Jan; 104(1):91-100. PubMed ID: 21139584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading.
    Wohlschlaeger J; Schmitz KJ; Takeda A; Takeda N; Vahlhaus C; Stypmann J; Schmid C; Baba HA
    J Heart Lung Transplant; 2010 Jan; 29(1):117-24. PubMed ID: 20123249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.
    Ramana KV; Tammali R; Srivastava SK
    Mol Cancer Ther; 2010 Apr; 9(4):813-24. PubMed ID: 20354121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas.
    Divakar SK; Ramana Reddy MV; Cosenza SC; Baker SJ; Perumal D; Antonelli AC; Brody J; Akula B; Parekh S; Reddy EP
    Leukemia; 2016 Jan; 30(1):86-93. PubMed ID: 26174628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell Cycle Dysregulation in Mantle Cell Lymphoma: Genomics and Therapy.
    Wang K; Huang X; Di Liberto M; Chen-Kiang S
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):809-823. PubMed ID: 32861279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.
    Lucas DM; Edwards RB; Lozanski G; West DA; Shin JD; Vargo MA; Davis ME; Rozewski DM; Johnson AJ; Su BN; Goettl VM; Heerema NA; Lin TS; Lehman A; Zhang X; Jarjoura D; Newman DJ; Byrd JC; Kinghorn AD; Grever MR
    Blood; 2009 May; 113(19):4656-66. PubMed ID: 19190247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
    Quintanilla-Martinez L; Davies-Hill T; Fend F; Calzada-Wack J; Sorbara L; Campo E; Jaffe ES; Raffeld M
    Blood; 2003 Apr; 101(8):3181-7. PubMed ID: 12515730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M; Hacohen D; Ginsberg D
    Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.
    Vogt N; Abramov D; Koch K; Masqué-Soler N; Szczepanowski M; Klapper W
    Leuk Lymphoma; 2015 Jul; 56(7):2134-40. PubMed ID: 25315075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma.
    Mishra PB; Lobo AS; Joshi KS; Rathos MJ; Kumar GA; Padigaru M
    J Transl Med; 2013 Feb; 11():42. PubMed ID: 23414419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS; Zhou J; Ong CN; Shen HM
    Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AZ703, an imidazo[1,2-a]pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9.
    Cai D; Byth KF; Shapiro GI
    Cancer Res; 2006 Jan; 66(1):435-44. PubMed ID: 16397259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
    Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
    Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma.
    Liu Q; Alinari L; Chen CS; Yan F; Dalton JT; Lapalombella R; Zhang X; Mani R; Lin T; Byrd JC; Baiocchi RA; Muthusamy N
    Clin Cancer Res; 2010 Jun; 16(12):3182-92. PubMed ID: 20460491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.